MMP-3 inhibitors (Allosterix)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMMP-3 inhibitors (Allosterix)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMatrix metalloproteinase 3 inhibitors
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsAutoimmune DiseasesOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllosterix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllosterix Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A